Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Madrigal Pharmaceuticals Inc (NQ: MDGL )

269.20 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Madrigal Pharmaceuticals Inc

< Previous 1 2 3 4 Next >
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,800 Today
 
Via Benzinga
Stock Market Falls Sharply Again As Tesla Dives, Micron Hits Chips; Nike, FedEx Strong: Weekly Review
The market uptrend is under pressure. 
Via Investor's Business Daily
Universal Health Services, Madrigal Pharmaceuticals And These Overbought Majors In The Healthcare Sector
The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
Why Madrigal Pharmaceuticals Was a Top Stock This Week
Biotech bulls stampeded the company following its latest clinical update. 
Via The Motley Fool
7 Drug Stocks That Will Soar in 2023
These drug stocks to buy look poised to generate huge profits for investors in 2023 and in subsequent years. 
Via InvestorPlace
Analyst Ratings for Madrigal Pharmaceuticals
 
Via Benzinga
Madrigal Shares Skyrocket After Successful NASH Study
 
Via Benzinga
Earnings Optimism Puts Wind In Wall Street's Sails
The major indexes are extending their rally off a mid-December losing streak. 
Via Talk Markets
Top M&A Target: Madrigal Pharmaceuticals Could Be Next After Successful NASH Data, Analyst Says
 
Via Benzinga
Madrigal Pharmaceuticals Gets Price Target Bumps By Analysts Following Successful NASH Study
Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) announced positive topline results from the pivotal Phase 3 MAESTRO-NASH biopsy trial of resmetirom. Madrigal Pharmaceuticals shares jumped 268.1% to close... 
Via Benzinga
Peering Into Madrigal Pharmaceuticals's Recent Short Interest
Madrigal Pharmaceuticals's (NASDAQ:MDGL) short percent of float has risen 3.82% since its last report. The company recently reported that it has 2.16 million shares sold short, which is 15.49% of all... 
Via Benzinga
Tesla To $285? Here Are 10 Other Price Target Changes For Tuesday
Wells Fargo raised Ross Stores, Inc. (NASDAQ: ROST) price target from $120 to $135. Wells Fargo analyst Ike Boruchow maintained an Overweight rating on the stock. Ross Stores shares fell 0.9% to close... 
Via Benzinga
Here's How An Options Trader Made $5.5 Million In One Day
Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) shares rose sharply on Monday after the company announced positive topline results from the pivotal Phase 3 MAESTRO-NASH (fatty liver disease) 
Via Benzinga
Tesla, Amazon, Apple, Madrigal, Walt Disney: Why These 5 Stocks Are Drawing Investors' Attention Today
Major Wall Street indices closed in the red on Monday as investor optimism on the much-anticipated Santa Claus rally began to fade over fears of recession gaining momentum. 
Via Benzinga
Healthcare Portfolio Is Doing Well But Biotech Stocks Are Mired In Macro
The biotech sector has not done well in 2022 despite some strong runs. Small and mid-cap stocks are more “risk-off’ with interest rates rising and sentiment waning. 
Via Talk Markets
Dow Struggles To Maintain Morning Gains
This morning's rally was short-lived, and by midday, the major indexes were trading back in the red amid looming recession anxieties. 
Via Talk Markets
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. 
Via Benzinga
Why Madrigal Pharmaceuticals Stock Is Crushing It Today
The company reported stellar late-stage clinical trial results for its experimental NASH (nonalcoholic steatohepatitis) drug. 
Via The Motley Fool
Madrigal Pharmaceuticals, Cerevel Therapeutics And Some Other Big Stocks Moving Higher On Monday
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 90 points on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Tesla's Bouncing, but This Nasdaq Stock Tripled Monday Morning
Good news can come in different forms. 
Via The Motley Fool
Why Is Viking Therapeutics (VKTX) Stock Up 67% Today?
Viking Therapeutics (VKTX) stock is taking off on Monday with heavy trading without any news from the biopharmaceutical company. 
Via InvestorPlace
AJRD Stock Alert: What to Know as L3Harris Technologies Acquires Aerojet Rocketdyne
Aerojet Rocketdyne (AJRD) stock is on the move today as investors react to a $4.7 billion deal with L3Harris Technologies (LHX). 
Via InvestorPlace
Why Viking Therapeutics Stock Is Moving Alongside Madrigal Pharmaceuticals Shares Today
Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Monday, in sympathy with Madrigal Pharmaceuticals Inc (NASDAQ: MDGL), which announced a suc 
Via Benzinga
Why Is Madrigal Pharmaceuticals (MDGL) Stock Up 216% Today?
Madrigal Pharmaceuticals (MDGL) stock is rocketing higher on Monday after sharing positive results from its NASH treatment. 
Via InvestorPlace
Madrigal Pharma Stock Triples After Knocking NASH Study Out Of The Park
The company hit both of its goals in a Phase 3 study of a pill for the liver disease. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Tesla, Amazon, Madrigal Pharma, Pfizer, Synaptogenix: Why These 5 Stocks Are Drawing Investors' Attention Today
Major Wall Street indices had closed in the red on Friday in the wake of a continued sell-off following the hawkish stance asserted by the Federal Reserve. Friday witnessed volatile trading as a large... 
Via Benzinga
2 Healthcare Stocks Poised to Rocket Higher in the 4th Quarter
These two healthcare stocks could deliver market-crushing gains by year's end. 
Via The Motley Fool
Madrigal Pharmaceuticals: Q3 Earnings Insights
Madrigal Pharmaceuticals (NASDAQ:MDGL) reported its Q3 earnings results on Thursday, November 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.